doi:10.3969/j.issn.1671-2587.2022.01.028

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2022, Vol. 24 ›› Issue (1): 126-131.DOI: 10.3969/j.issn.1671-2587.2022.01.028

Previous Articles Next Articles

Received:2021-10-12 Published:2022-01-27

[1] IBA T,LEVY J H.Inflammation and thrombosis:roles of neutrophils,platelets and endothelial cells and their interactions in Thrombus formation during Sepsis[J]. J Thromb Haemost,2018,16(2):231-241.
[2] MONTEIRO J,LEPENIES B.Myeloid C-type lectin receptors in viral recognition and antiviral immunity[J]. Viruses,2017,9(3):59.
[3] SUNG P S,HUANG T F,HSIEH S L.Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2[J]. Nat Commun,2019,10(1):2402.
[4] OSADA M,INOUE O,DING G,et al.Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation,migration,and tube formation of lymphatic endothelial cells[J]. J Biol Chem,2012,287(26):22241-22252.
[5] SUZUKI-INOUE K,OSADA M,OZAKI Y.Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin:partners from in utero to adulthood[J].J Thromb Haemost,2017,15(2):219-229.
[6] LAX S,RAYES J,WICHAIYO S,et al.Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse[J]. Am J Physiol Lung Cell Mol Physiol,2017,313(6):L1016-L1029.
[7] SUZUKI-INOUE K,TSUKIJI N,SHIRAI T,et al.Platelet CLEC-2:roles beyond hemostasis[J]. Semin Thromb Hemost,2018,44(2):126-134.
[8] RAYES J,WATSON S P,NIESWANDT B.Functional significance of the platelet immune receptors GPVI and CLEC-2[J]. J Clin Invest,2019,129(1):12-23.
[9] 宗晓龙,李真玉,谷雅君,等.血小板参与免疫炎症反应的研究进展[J]. 中华微生物学和免疫学杂志,2018,38(4):313-320.
[10] HAMZEH-COGNASSE H,BERTHELOT P,TARDY B,et al.Platelet toll-like receptors are crucial sensors of infectious danger moieties[J]. Platelets,2018,29(6):533-540.
[11] ZHANG G Y,HAN J Y,WELCH E J,et al.Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway[J]. J Immunol,2009,182(12):7997-8004.
[12] VALLANCE T M,RAVISHANKAR D,ALBADAWI D A I,et al. Effect of ultrapure lipopolysaccharides derived from diverse bacterial species on the modulation of platelet activation[J].Sci Rep,2019,9(1):18258.
[13] CLAUSHUIS T A M,VAN DER VEEN A I P,HORN J,et al. Platelet Toll-like receptor expression and activation induced by lipopolysaccharide and Sepsis[J]. Platelets,2019,30(3):296-304.
[14] VOGEL S,BODENSTEIN R,CHEN Q W,et al.Platelet-derived HMGB1 is a critical mediator of thrombosis[J]. J Clin Invest,2015,125(12):4638-4654.
[15] LI Z Y,XI X D,GU M Y,et al.A stimulatory role for cGMP-dependent protein kinase in platelet activation[J].Cell,2003,112(1):77-86.
[16] YANG H,HREGGVIDSDOTTIR H S,PALMBLAD K,et al.A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release[J]. PNAS,2010,107(26):11942-11947.
[17] BISWAS S,ZIMMAN A,GAO D T,et al.TLR2 plays a key role in platelet hyperreactivity and accelerated thrombosis associated with hyperlipidemia[J]. Circ Res,2017,121(8):951-962.
[18] KOUPENOVA M,CORKREY H A,VITSEVA O,et al.The role of platelets in mediating a response to human influenza infection[J]. Nat Commun,2019,10(1):1780.
[19] KATHARINA F,YAMEL C G,OLAF-OLIVER W,et al. The fungal ligand chitin directly binds TLR2 and triggers inflammation dependent on oligomer size[J]. EMBO Rep,2018,19(12):n/a.
[20] LEROY J,BORTOLUS C,LECOINTE K,et al.Fungal chitin reduces platelet activation mediated via TLR8 stimulation[J]. Front Cell Infect Microbiol,2019,9:383.
[21] GAO W,XIONG Y,LI Q,et al.Inhibition of toll-like receptor signaling as a promising therapy for inflammatory diseases:a journey from molecular to nano therapeutics[J]. Front Physiol,2017,8:508.
[22] HALLY K E,LA FLAMME A C,HARDING S A,et al. The effects of aspirin and ticagrelor on Toll-like receptor (TLR)-mediated platelet activation:results of a randomized,cross-over trial[J]. Platelets,2019,30(5):599-607.
[23] ZHANG S,ZHANG S H,HU L,et al.Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis[J]. Circulation,2015,131(13):1160-1170.
[24] 陈华,高稳,温志超,等.炎性受体NOD2在心房颤动病人血小板中的表达意义[J]. 中西医结合心脑血管病杂志,2018,16(19):2842-2844.
[25] CORNELIUS D C,BAIK C H,TRAVIS O K,et al.NLRP 3 inflammasome activation in platelets in response to Sepsis[J]. Physiol Rep,2019,7(9):e14073.
[26] CORNELIUS D C,TRAVIS O K,TRAMEL R W,et al.NLRP3 inflammasome inhibition attenuates Sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture[J].PLoS One,2020,15(6):e0234039.
[27] 殷均奎,赵庆彦. NLRP3炎症小体在心血管疾病中作用的研究进展[J]. 医学综述,2020,26(1):6-11.
[28] QIAO J L,WU X Q,LUO Q,et al.NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling,hemostasis and arterial thrombosis[J]. Haematologica,2018,103(9):1568-1576.
[29] VOGEL S,MURTHY P,CUI X D,et al.TLR4-dependent upregulation of the platelet NLRP3 inflammasome promotes platelet aggregation in a murine model of hindlimb ischemia[J]. Biochem Biophys Res Commun,2019,508(2):614-619.
[30] PENG H T,WU H Y,ZHANG G,et al.Expression and clinical prognostic value of platelet NLRP3 in acute coronary syndrome[J]. Int J Gen Med,2020,13:791-802.
[31] EVERETT B M,CORNEL J H,LAINSCAK M,et al.Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure[J]. Circulation,2019,139(10):1289-1299.
[32] SALAMAH M F,RAVISHANKAR D,VAIYAPURI R,et al.The formyl peptide fMLF primes platelet activation and augments Thrombus formation[J]. J Thromb Haemost,2019,17(7):1120-1133.
[33] HELMS J,TACQUARD C,SEVERAC F,et al.High risk of thrombosis in patients with severe SARS-CoV-2 infection:a multicenter prospective cohort study[J]. Intensive Care Med,2020,46(6):1089-1098.
[34] MANNE B K,DENORME F,MIDDLETON E A,et al.Platelet gene expression and function in patients with COVID-19[J]. Blood,2020,136(11):1317-1329.
[35] SRIRAM K,INSEL P A.Proteinase-activated receptor 1:a target for repurposing in the treatment of COVID-19?[J]. Br J Pharmacol,2020,177(21):4971-4974.
[36] MORAES L A,UNSWORTH A J,VAIYAPURI S,et al.Farnesoid X receptor and its ligands inhibit the function of platelets[J]. Arterioscler Thromb Vasc Biol,2016,36(12):2324-2333.
[37] CHEN X,ZHAO X F,COOPER M,et al.The roles of GRKs in hemostasis and thrombosis[J]. Int J Mol Sci,2020,21(15):5345.
[38] CHAUDHARY P K,KIM S,JEE Y,et al.Role of GRK6 in the regulation of platelet activation through selective G protein-coupled receptor (GPCR) desensitization[J]. Int J Mol Sci,2020,21(11):3932.
[39] ROSSAINT J,KÜHNE K,SKUPSKI J,ET AL. DIRECTED TRANSPORT OF NEUTROPHIL-DERIVED EXTRACELLULAR VESICLES ENABLES PLATELET-MEDIATED INNATE IMMUNE RESPONSE[J]. NAT COMMUN,2016,7:13464.
[40] MCDONALD B,DAVIS R P,KIM S J,et al.Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during Sepsis in mice[J]. Blood,2017,129(10):1357-1367.
[41] SCHMID W,NOVACEK G,VOGELSANG H,et al.Platelets toll-like receptor-4 in crohns disease[J]. Eur J Clin Invest,2017,47(2):109-116.
[42] BADRNYA S,SCHROTTMAIER W C,KRAL J B,et al.Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation[J]. Arterioscler Thromb Vasc Biol,2014,34(3):571-580.
[43] D'MELLO C,ALMISHRI W,LIU H Q,et al.Interactions between platelets and inflammatory monocytes affect sickness behavior in mice with liver inflammation[J]. Gastroenterology,2017,153(5):1416-1428.e2.
[44] ALLEN N,BARRETT T J,GUO Y,et al.Circulating monocyte-platelet aggregates are a robust marker of platelet activity in cardiovascular disease[J]. Atherosclerosis,2019,282:11-18.
[45] COLBERG L,CAMMANN C,GREINACHER A,et al.Structure and function of the ubiquitin-proteasome system in platelets[J]. J Thromb Haemost,2020,18(4):771-780.

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 389-391.
[2]	SUN Jia-feng, YANG Xiao-jun, ZHANG Ai, et al. Study on Serological and Molecular Biological Characteristics of 3 Cases with B Subtype [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 506-509.
[3]	SU Mu-ya, DU Hua, SHI Ying-xu. In Vitro Expansion of Human Umbilical Cord Blood Regulatory T Cells by Magnetic Beads [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 526-530.
[4]	FANG Huan-ying, Gao Ji-juan, Chu Min, et al. Clinical Significance of Absolute Eosinophil Counts in Patients with Chronic Renal Diseases [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(2): 148-151.
[5]	WEI Xiao-zhu, SU Wei, CHEN Wang, et al. The Correlation between The Prevalence of Hyperuricemia and The Polymorphisms of SLC2A9 Gene Rs2241480 in Coastal Population [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(2): 160-164.
[6]	NIE Li-rong, LI Qing-hua, LIANG Liang, et al. The Effect of Bortezomib-Combined Chemotherapy on Multiple Myeloma and VEGF, IL-6 and IL-17 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(2): 211-214.
[7]	MA Hui-bo, DU Jing-jing. Correlation between Serum DAPK,MGMT DNA Methylation and Pathological Metastasis Features of Lung Cancer [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(1): 51-54.
[8]	SHEN Ji-min, LIU Xin, WANG Xing-bing. Effects of TLR-3 Agonists Combined with TLR-9 Agonists on Cell Morphology and Immunophenotype of Dendritic Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(1): 71-76.
[9]	LIU Ai-ling, LIU Ai-sheng, LUO Xiao-fang, et al. Establishment and Preliminary Application of Intestinal Rotavirus （RV） Nested PCR Detection Method [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(6): 604-607.
[10]	AN Li-ying, WANG Peng, FENG Rui-gang, et al. Values of 21 Genetic Markers Scoring for the Risk of Recurrence in Breast Cancer [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(6): 626-629.
[11]	ZHENG Yan-mei, GAO Jian, CHAI Sheng-jiang. Investigation and Analysis of Clinical Blood Work in Xiangyang Area [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(5): 471-473.
[12]	YE Fang, HUANG Ting-ting, XU Hui, et al. Relationship between Folate Metabolism Related Enzyme Gene Polymorphism and Adverse Pregnancy Outcomes [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(5): 514-516.
[13]	LIANG Zhi-hong, XIE Jing-wen, RUAN Li-fen, et al. RHD Gene Genotyping in Pregnant Women with Rare Blood Type [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(4): 348-351.
[14]	SU Man, WANG Zhen-lei, HU Guang-lei, et al. Analysis of HLA-DQB1 Gene Polymorphism in 1 914 Han Nationality Population in Hebei Province [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(4): 380-382.
[15]	ZHU YU-Li, GAO Xiang-yang, LIU Li. A Case Report Of Di(a+b-) Blood Group with Anti-Dib Antibody [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(4): 438-441.